OCGN Q2 2024 Earnings — Ocugen, Inc. Revenue & Financial Results | Market Cap Arena

OCGNOcugen, Inc.

$578M

Q2 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1M+135.3% YoY

Gross Profit

$1M100.0% margin

Operating Income

-$15M-1354.0% margin

Net Income

-$15M-1339.2% margin

EPS (Diluted)

$-0.04

QoQ Revenue Growth

+12.5%

Cash Flow

Operating Cash Flow

-$10M

Free Cash Flow

-$10M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$41M

Total Liabilities

$24M

Stockholders' Equity

$17M

Cash & Equivalents

$16M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1M	$485,000	+135.3%
Gross Profit	$1M	-$14M	+108.1%
Operating Income	-$15M	-$24M	+34.4%
Net Income	-$15M	-$23M	+33.8%